TaiGen Biotechnology taigenbiotech.com


TaiGen Biotechnology is a research-based and product-driven pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer and diabetes-related complications. TaiGen has a wholly-owned Beijing subsidiary with a proven capacity to conduct clinical trials and related registrations.

TaiGen Biotechnology is a research-based and product-driven pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer and diabetes-related complications. TaiGen has a wholly-owned Beijing subsidiary with...Show all

Company (IPO / Went public)

Phone: 886-2-81777072

Fax:

7F,138 Shin Ming Rd. Neihu Dist

Taipei, 114 R.O.C.
Taiwan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
TaiGen Biotechnology $73M Jan 21, 2014
GPC Biotech $0M Mar 6, 2000
Epix Pharmaceuticals $38.1M Jul 21, 2009
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related TaiGen Biotechnology Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Lyophilization formulation Nov 12, 2009 May 05, 2015 Patent
Hcv protease inhibitors Sep 15, 2009 Mar 05, 2013 Patent
Heterocyclic compounds Nov 03, 2008 Feb 12, 2013 Patent
Coupling process for preparing quinolone intermediates Oct 27, 2008 Apr 17, 2012 Patent